(Q50951166)

25 March 2018

title

Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. (English)

1 reference

25 March 2018

1 reference

Jadoul M

1

1 reference

25 March 2018

Garbar C

2

1 reference

25 March 2018

Noël H

3

1 reference

25 March 2018

Sennesael J

4

1 reference

25 March 2018

Vanholder R

5

1 reference

25 March 2018

Bernaert P

6

1 reference

25 March 2018

Rorive G

7

1 reference

25 March 2018

Hanique G

8

1 reference

25 March 2018

van Ypersele de Strihou C

9

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

25 March 2018

published in

Kidney International

1 reference

25 March 2018

volume

51

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

1928-1932

1 reference

25 March 2018

Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Dialysis-related amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Clinical implications of hemodialysis membrane biocompatibility

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Microdeposition of amyloid in the joints

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Beta-2-microglobulin-derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Learning from the Japanese Registry: how will we prevent long-term complications? Niigata Research Programme for beta 2-M Removal Membrane.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.262

7 January 2021

Identifiers

DOI

10.1038/KI.1997.262

1 reference

25 March 2018

1 reference

25 March 2018